IGF-1 LR3
IGF-1 LR3 is a long-acting analog of insulin-like growth factor 1 with an extended N-terminal sequence and Arg3 substitution for increased stability and potency. Preclinical research explores its potent effects on anabolic signaling and cell growth.
Key Research Areas
- • Studied for potent stimulation of cell proliferation and protein synthesis via IGF-1 receptor signaling.
- • Investigated for enhancement of muscle hypertrophy and recovery in exercise, injury, and metabolic research models.
- • Explored for anabolic and metabolic effects in various tissue regeneration and performance paradigms.
Product Specifications
| Product |
IGF-1 LR3 |
| CAS Number |
143045-27-6 (or research-specific) |
| Molecular Formula |
C400H625N111O115S9 |
| Molar Mass |
~9117 g/mol |
| Sequence |
Modified 83-amino acid IGF-1 analog (LR3) with Arg3 substitution and N-terminal extension for extended half-life |
| Synonyms |
IGF-1 LR3; Long R3 IGF-1; LR3-IGF-1 |
| Purity |
≥99% (HPLC) |
| Form |
Lyophilized powder |
| Storage |
−20°C (−4°F) long-term; 2–8°C (36–46°F) reconstituted |
| Solubility |
Bacteriostatic water for laboratory use |
All products offered by Premier Research are intended for laboratory research use only. These materials are not for human or veterinary consumption, medical use, diagnostic procedures, or therapeutic applications. Statements on this website are for informational and educational purposes only and have not been evaluated by the U.S. Food and Drug Administration (FDA). By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines.
